2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics 2008 Barcelona - European Society of Human Genetics

24.08.2013 Views

Concurrent Sessions c07.1 Oligosaccharyltransferase subunits mutations in non-syndromic mental retardation F. Molinari 1 , F. Foulquier 2 , P. S. Tarpey 3 , W. Morelle 2 , J. Teague 3 , S. Edkins 3 , P. A. Futreal 3 , M. R. Stratton 3 , G. Turner 4 , G. Matthijs 5 , J. Gecz 6 , A. Munnich 1 , L. Colleaux 1 ; 1 INSERM U781 and Université Paris Descartes, Paris, France, 2 UMR CNRS/ USTL 8570, Lille, France, 3 Wellcome Trust Sanger Institute, Cambridge, United Kingdom, 4 The Gold Service, Adelaide, Australia, 5 Laboratory for Molecular Diagnostics, Center for Human Genetics, Leuven, Belgium, 6 Department of Pediatrics and School of Molecular & Biomedical Science, University of Adelaide, Adelaide, Australia. Mental Retardation (MR) is the most frequent handicap among children and young adults . While a large proportion of X-linked MR genes have been identified, only four genes of autosomal recessive non-syndromic MR (AR-NSMR) have been described so far . Here, we report on two new genes involved in autosomal and X-linked NSMR. First, autozygosity mapping in two sibs born to first cousin French family led to the identification of a region on 8p23.1-p22. This interval encompasses the gene N33/TUSC3 encoding one subunit of the oligosaccharyltransferase (OTase) complex which catalyses the transfer of an oligosaccharide chain on nascent proteins, the key step of N-Glycosylation . Sequencing N33/TUSC3 identified a one basepair insertion, c .787_788insC, resulting in a premature stop codon, p .N263fsX300, and leading to mRNA decay . Surprisingly, glycosylation analyses of patient fibroblasts showed normal N-glycan synthesis and transfer . Subsequently, screening the X-linked N33/TUSC3 paralog, the IAP gene, identified a missense mutation (c.932T>G, p.V311G) in two brothers with X-linked NSMR . Interestingly, quantitative RT-PCR analyses showed increased IAP expression in N33/TUSC3 mutated cells, suggesting that normal N-glycosylation observed in patient fibroblasts may be due to functional compensation . Recent studies of fucosylation and polysialic acid modification of neuronal cell adhesion glycoproteins have shown the critical role of glycosylation in synaptic plasticity. However, our data provide the first demonstration that a defect in N-Glycosylation can result in NSMR . Altogether, our results demonstrate that fine regulation of OTase activity is essential for normal cognitive function development, providing therefore new insights to understand the pathophysiological bases of MR . c07.2 Influence of Friedreich ataxia GAA non-coding repeats expansions on pre-mRNA processing F. Pagani; ICGEB, Trieste, Italy. The intronic GAA repeat expansion in the frataxin gene causes the hereditary neurodegenerative disorder Friedreich’s ataxia . While it is generally believed that GAA repeats block transcription elongation, a direct proof in eukaryotic system is lacking . We tested in hybrid minigenes the effect of GAA and TTC repeats on nascent transcription and pre mRNA processing . Unexpectedly, disease-causing GAA repeats (n=100) did not affect transcriptional elongation in nuclear HeLa RUN ON assay nor pre mRNA transcript abundance but resulted in a complex defect on pre mRNA processing . GAA but not TTC repeats insertion downstream of reporter exons resulted in their partial or complete exclusion from the mature mRNAs and in the generation of a variety of aberrant splicing products . Interestingly, the GAA expansion induced the accumulation of an upstream pre mRNA splicing intermediate, which is not turned over into mature mRNA . This effect of GAA repeats was observed to be position and context-dependent, as their insertion at different distance from the reporter exons had a variable effect on splice site selection . Reduction of GAA triplets partially restored normal splicing consistent with a repeat length dependent phenotypic variability . This data indicates, for the first time, an association between GAA non-coding repeats and aberrant pre-mRNA processing and suggests an alteration of the coordination between transcription and pre-mRNA processing in this disease . Transcribed GAA repeats might create a “decoy” exon that binding to trans acting splicing factors may interfere with normal turnover of non-coding intronic RNA leading to degradation and lower transcript levels . c07.3 mechanisms of mEcP2 function underlying Rett syndrome as revealed from overexpression and knock-down systems in vitro M. Vecsler 1,2 , A. J. Simon 1,3 , G. Rechavi 1,3 , N. Amariglio 1,3 , E. Gak 1,2 ; 1 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 2 Genetics Institute, Sheba Medical Center, Tel Hashomer, Israel, 3 Cancer Research Center, Institute of Hematology, Sheba Medical Center, Tel Hashomer, Israel. Rett syndrome is a severe X-linked neurodevelopmental disorder mainly affecting girls and is the second common cause of mental retardation in girls after the Down syndrome . The methyl CpG-binding protein 2 (MeCP2), a ubiquitous transcriptional repressor interacting with the chromatin remodeling machinery, is considered a single causative factor of Rett syndrome and related phenotypes, and some autistic cases . Our present study is focusing on interaction between MeCP2 and chromatin proteins leading to changes in chromatin architecture and silencing of gene expression . Using confocal microscopy, we demonstrate that MeCP2 protein is localized at the nuclear heterochromatin compartment together with the heterochromatin protein 1 alpha (HP1α). In addition, we have developed in-vitro systems overexpressing the normal MeCP2 and MeCP2 containing Rett related mutations, as well as a knock-down system of the endogenous MECP2 using specific siRNA. Studying these systems with a comprehensive gene regulation antibody array, we demonstrate that the expression of a specific set of nuclear proteins, including hBRM/hSNF2a component of SWI/SNF, HMGB1 high mobility group protein, G9a histone methyltransferase, PRMT1 protein arginine methyltransferase and HDAC2 histone deacetylase, is synchronized with MeCP2 overexpression and knock-down . Moreover using co-immunoprecipitation analyses, we demonstrate a direct interaction between MeCP2 and hBRM/hSNF2a component of ATPase-dependent SWI/SNF complex involved in global chromatin remodeling mechanism. Our findings suggest that MeCP2 acts through parallel mechanism of chromatin remodeling involving HDACs and SWI/SNF complex, thereby inducing local as well as large scale changes in chromatin architecture and compaction . c07.4 mutations in UBE are associated with X-linked infantile spinal muscular atrophy (XL-smA) and cause decreased gene expression in patients and carrier females A. Meindl1 , J. Ramser1 , C. Lenski1 , M. von Rhein2 , B. Wirth3 , K. O. Yariz4 , M. E. Ahearn4 , L. Baumbach-Reardon4 ; 1Department of Obstetrics and Gynecology, Technical University Munich, Munich, Germany, 2University Children’s Hospital Mainz, Mainz, Germany, 3 4 Institute of Human Genetics, University of Cologne, Cologne, Germany, Miller School of Medicine, University of Miami, Miami, FL, United States. X-linked infantile spinal-muscular atrophy (XL-SMA; MIM301830) is a rare X-linked disorder that presents with the clinical features of hypotonia, areflexia and multiple congenital contractures (arthrogryposis) associated with anterior horn cell loss and infantile death . Large scale mutation analysis in the linkage interval (DXS8080-DXS7132) resulted in the detection of three rare novel variants in exon 15 of the gene coding for the Ubiquitin-Activating Enzyme E1 (UBE1): two missense mutations (c .1617 G>T, p .Met539Ile, c .1639 A>G, p .Ser547Gly) present each in one XL-SMA family and one synonymous C>T substitution (c.1731 C>T, p.Asn577Asn) identified in additional four unrelated families . Each of these variants was demonstrated to segregate with the disease . Absence of the missense mutations was demonstrated for 3550, absence of the silent mutation was shown in 7914 control X-chromosomes. These results yielded statistical significant evidence for the association of the silent substitution and the two missense mutations with XL-SMA (P = 2 .416x10-10 , P = 0 .001815) . We have also demonstrated that the silent C>T substitution leads to significant reduction of UBE1-expression in patients and interestingly to a lesser extent also in carrier females and alters the methylation pattern of exon 15, implying a plausible role of this DNA element in developmental UBE1- expression in humans . UBE1 catalyzes in the ubiquitin-proteasome system (UPS) the first step in ubiquitin conjugation to mark cellular proteins for degradation . Our observations indicate that XL-SMA is part of a growing list of neurodegenerative disorders associated with defects in the ubiquitin-proteasome pathway .

Concurrent Sessions c07.5 VLDLR (very low density lipoprotein receptor) is the first gene implicated in cerebellar hypoplasia and quadrupedal locomotion in humans T. H. Ozcelik 1 , N. Akarsu 2 , E. Uz 1 , S. Caglayan 1 , S. Gulsuner 1 , O. E. Onat 1 , M. Tan 3 , U. Tan 4 ; 1 Bilkent University, Ankara, Turkey, 2 Hacettepe University, Ankara, Turkey, 3 Baskent University, Ankara, Turkey, 4 Cukurova University, Adana, Turkey. Quadrupedal gait in humans is a rare phenotype . We studied four consanguineous families, reported as Unertan syndrome, all exhibiting quadrupedal gait, dysarthric speech, mental retardation, and varying degrees of cerebro-cerebellar hypoplasia . Homozygosity mapping linked the locus for this unique autosomal-recessive trait to chromosome 9p24 in families A & D and 17p13 in family B . Family C excluded linkage to both loci . These results suggest that hereditary disorders associated with quadrupedal gait are genetically heterogenous . The 9p24 region includes the gene VLDLR, which is a component of the reelin signaling pathway . Sequence analysis of VLDLR revealed two distinct mutations, R257X in family A, and I780TfsX3 in family D . Both of these mutations presumably truncate the protein, apparently leaving behind a non-functional product . Unlike chromosome 9p24, the chromosome 17p interval is large and contains at least 157 genes . We adopted a bioinformatics approach to screen the 17p interval for tri nucleotide repeats GAA, CAG, CGG and CTG, and neuronal expression . This analysis revealed several genes including lissencephaly-1 (LIS1, alternative symbol PAFAH1B1) . LIS1 interacts with VLDLR, and heterozygous LIS1 mutations in humans cause lissencephaly I . Neither LIS1 nor four additional genes (WDR81, RUTBC1, MNT, TRPV1) showed an expansion of their repeat sequences . The search for the chromosome 17p13 gene in Family B continues . Our data suggest that mutations in VLDLR impair cerebro-cerebellar function and confer a dramatic influence on gait in humans. Supported by grants TUBITAK-SBAG 3334 and ICGEB-CRP/TUR04- 01 (to TO); Baskent University Research Fund KA 07/47 and TUBI- TAK-SBAG-HD-230 (to MT) . c07.6 The utilization of T3/T4 screening of males with MR of unknown etiology to identify patients with Allan-Herndon-Dudley syndrome T. Wood 1 , D. Hobson 2 , B. Browning 1 , C. Rogers 1 , C. Skinner 1 , H. H. Ardinger 3 , F. Collins 4 , A. Aronsky 5 , M. J. Friez 1 , C. E. Schwartz 1 ; 1 Greenwood Genetic Center, Greenwood, SC, United States, 2 Wake Forest University, Winston-Salem, NC, United States, 3 Children’s Mercy Hospitals and Clinics, Kansas City, MO, United States, 4 Western Sydney Genetic Program, Sydney, Australia, 5 Newark New Jersey, Newark, NJ, United States. Allan-Herndon-Dudley syndrome (AHD; OMIM 309600) is an X-linked recessive disorder presenting with hypotonia progressing to spasticity, delay in developmental milestones, and severe mental retardation . Mutations in the MCT8/SLC16A2 gene have shown to be causative in clinically diagnosed AHD patients . MCT8 functions as a thyroid hormone transporter with an essential function in the transport of triiodothyronine (T3) into neurons . An imbalance of certain plasma thyroid hormones has been identified in AHD patients. To investigate the clinical utility of thyroid screening in patients with MR, we measured free T3 and free T4 in a cohort of 137 males with MR of unknown etiology. Twenty males were identified to have elevated T3 and molecular analysis of MCT8 in these patients identified two (10%) with pathogenic changes . One mutation was an insertion of 2 amino acids, p .G41_S42 dup, in exon 1 . The 40 year old male had profound MR, was ambulatory and non-verbal . He also had a seizure disorder and a right spastic hemiparetic arm . The second mutation (p .G282C) was in a 5 year old boy with truncal hypotonia and hypertonia of his extremities with spasticity, dystonia and hyperreflexia - all consistent with AHD . Additionally, 28 males enrolled in our XLMR study, with clinical or biochemical evaluations suggestive of AHD, were analyzed for MCT8 mutations and seven (25%) had pathogenic changes . Based on our results, testing the T3 level may serve as a general screen for the AHD syndrome and should certainly be considered in males with significant mental retardation and hypotonia . c08.1 the role of the interferon regulatory factor 5 gene in autoimmune diseases G. Kristjansdottir 1 , S. Sigurdsson 1 , J. Sandling 1 , V. Dideberg 1,2 , H. Göring 3 , L. Milani 1 , V. Bours 2 , F. Matesanz 4 , L. Rönnblom 5 , A. C. Syvänen 1 ; 1 Molecular medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 2 Department of Human Genetics, CHU de Liège, Liège, Belgium, 3 Department of Genetics Southwest Foundation for Biomedical Research, San Antonio, TX, United States, 4 Instituto de Parasitología y Biomedicina López Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain, 5 Section of Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. IRF5 is a transcription factor involved both in the type I interferon and toll-like receptor signalling pathways . We have found polymorphisms in the IRF5 gene to be associated with several autoimmune diseases; systemic lupus erythematosus 1 , rheumatoid arthritis 2 , multiple sclerosis 3 and inflammatory bowel disease 4 . By statistical methods two variants in the IRF5 gene have been shown to be independently associated to SLE . The variants are a CGGGG insertion-deletion (indel) polymorphism located in the promoter region of the IRF5 gene and a SNP rs10488631 located at the 3´end . The indel contains 3 or 4 repeats of the sequence CGGGG and the longer allele confers risk to all of the autoimmune diseases tested . The risk allele contains an additional binding site for the transcription factor SP1 . Using electrophoretic mobility shift assays (EMSA) we observed allele-specific differences in protein binding to the indel and by proximity ligation assay (PLA) we demonstrated increased binding of the transcription factor SP1 to the risk allele . Our study adds to the evidence that there might be genes or pathways that are common in multiple autoimmune diseases and that the type I interferon system is likely to be involved in the development of these diseases . 1) Sigurdsson S et al . Hum Mol Genet (2007) Dec 6 2) Sigurdsson S et al . Arthritis Rheum (2007) Jul;56(7):2202-10 4) Kristjansdottir G, Sandling J et al . J Med Genet accepted manuscript 3) Dideberg V et al . Hum Mol Genet (2007) Dec 15 c08.2 Elevated expression of serotonin receptor type 3 genes may contribute to irritable bowel syndrome with diarrhea J. Kapeller 1 , L. Houghton 2 , J. Walstab 3 , D. Möller 1 , H. Bönisch 3 , F. Autschbach 4 , N. Gassler 5 , C. Fischer 1 , P. Whorwell 2 , W. Atkinson 2 , C. Fell 2 , G. Rappold 1 , B. Niesler 1 ; 1 Institute of Human Genetics, Heidelberg, Germany, 2 University of Manchester, Manchester, United Kingdom, 3 Institute of Pharmacology and Toxicology, Bonn, Germany, 4 Institute of Pathology, Heidelberg, Germany, 5 Institute of Pathology, Aachen, Germany. Serotonin type 3 (5-HT 3 ) receptor antagonists are beneficial in some but not all patients with irritable bowel syndrome and diarrhea (IBS-D) . As cis-regulatory variants can play a role in the etiology of complex conditions by affecting efficiency of translation, we investigated the 5´ and 3´ untranslated region (UTR) of the 5-HT 3A and 5-HT 3E subunit genes . Mutation analysis was carried out in 200 patients with irritable bowel syndrome and 100 healthy controls . We found a HTR3A 5´UTR variant and a novel HTR3E 3´UTR variant associated with the IBS-D subtype. Functional studies showed that both variants lead to significant upregulation of subunit expression . In HEK293 cells, the HTR3A variant results in a higher density of 5-HT 3A receptors at the cell surface compared to the wild-type control . The HTR3E variant affects a microRNA binding site and leads to a higher luciferase reporter gene expression . Both HTR3E and the miRNA co-localize in enterocytes of the mucosal cell layer of the gut epithelium as shown by in situ hybridization . We suggest that the increased expression of 5-HT 3A and 5-HT 3E subunits might result in a change in 5-HT 3 receptor composition and/or density of 5-HT 3 receptors in the epithelial cell layer of the mucosa and neurons of the enteric and central nervous system and could therefore contribute to the pathophysiology of IBS-D .

Concurrent Sessions<br />

c07.1<br />

Oligosaccharyltransferase subunits mutations in non-syndromic<br />

mental retardation<br />

F. Molinari 1 , F. Foulquier 2 , P. S. Tarpey 3 , W. Morelle 2 , J. Teague 3 , S. Edkins 3 , P.<br />

A. Futreal 3 , M. R. Stratton 3 , G. Turner 4 , G. Matthijs 5 , J. Gecz 6 , A. Munnich 1 , L.<br />

Colleaux 1 ;<br />

1 INSERM U781 and Université Paris Descartes, Paris, France, 2 UMR CNRS/<br />

USTL 8570, Lille, France, 3 Wellcome Trust Sanger Institute, Cambridge, United<br />

Kingdom, 4 The Gold Service, Adelaide, Australia, 5 Laboratory for Molecular<br />

Diagnostics, Center for <strong>Human</strong> <strong>Genetics</strong>, Leuven, Belgium, 6 Department <strong>of</strong> Pediatrics<br />

and School <strong>of</strong> Molecular & Biomedical Science, University <strong>of</strong> Adelaide,<br />

Adelaide, Australia.<br />

Mental Retardation (MR) is the most frequent handicap among children<br />

and young adults . While a large proportion <strong>of</strong> X-linked MR genes<br />

have been identified, only four genes <strong>of</strong> autosomal recessive non-syndromic<br />

MR (AR-NSMR) have been described so far .<br />

Here, we report on two new genes involved in autosomal and X-linked<br />

NSMR. First, autozygosity mapping in two sibs born to first cousin<br />

French family led to the identification <strong>of</strong> a region on 8p23.1-p22. This<br />

interval encompasses the gene N33/TUSC3 encoding one subunit <strong>of</strong><br />

the oligosaccharyltransferase (OTase) complex which catalyses the<br />

transfer <strong>of</strong> an oligosaccharide chain on nascent proteins, the key step<br />

<strong>of</strong> N-Glycosylation . Sequencing N33/TUSC3 identified a one basepair<br />

insertion, c .787_788insC, resulting in a premature stop codon,<br />

p .N263fsX300, and leading to mRNA decay . Surprisingly, glycosylation<br />

analyses <strong>of</strong> patient fibroblasts showed normal N-glycan synthesis and<br />

transfer . Subsequently, screening the X-linked N33/TUSC3 paralog,<br />

the IAP gene, identified a missense mutation (c.932T>G, p.V311G) in<br />

two brothers with X-linked NSMR . Interestingly, quantitative RT-PCR<br />

analyses showed increased IAP expression in N33/TUSC3 mutated<br />

cells, suggesting that normal N-glycosylation observed in patient fibroblasts<br />

may be due to functional compensation .<br />

Recent studies <strong>of</strong> fucosylation and polysialic acid modification <strong>of</strong><br />

neuronal cell adhesion glycoproteins have shown the critical role <strong>of</strong><br />

glycosylation in synaptic plasticity. However, our data provide the first<br />

demonstration that a defect in N-Glycosylation can result in NSMR . Altogether,<br />

our results demonstrate that fine regulation <strong>of</strong> OTase activity<br />

is essential for normal cognitive function development, providing therefore<br />

new insights to understand the pathophysiological bases <strong>of</strong> MR .<br />

c07.2<br />

Influence <strong>of</strong> Friedreich ataxia GAA non-coding repeats<br />

expansions on pre-mRNA processing<br />

F. Pagani;<br />

ICGEB, Trieste, Italy.<br />

The intronic GAA repeat expansion in the frataxin gene causes the<br />

hereditary neurodegenerative disorder Friedreich’s ataxia . While it is<br />

generally believed that GAA repeats block transcription elongation, a<br />

direct pro<strong>of</strong> in eukaryotic system is lacking . We tested in hybrid minigenes<br />

the effect <strong>of</strong> GAA and TTC repeats on nascent transcription<br />

and pre mRNA processing . Unexpectedly, disease-causing GAA repeats<br />

(n=100) did not affect transcriptional elongation in nuclear HeLa<br />

RUN ON assay nor pre mRNA transcript abundance but resulted in a<br />

complex defect on pre mRNA processing . GAA but not TTC repeats<br />

insertion downstream <strong>of</strong> reporter exons resulted in their partial or complete<br />

exclusion from the mature mRNAs and in the generation <strong>of</strong> a<br />

variety <strong>of</strong> aberrant splicing products . Interestingly, the GAA expansion<br />

induced the accumulation <strong>of</strong> an upstream pre mRNA splicing intermediate,<br />

which is not turned over into mature mRNA . This effect <strong>of</strong> GAA<br />

repeats was observed to be position and context-dependent, as their<br />

insertion at different distance from the reporter exons had a variable effect<br />

on splice site selection . Reduction <strong>of</strong> GAA triplets partially restored<br />

normal splicing consistent with a repeat length dependent phenotypic<br />

variability .<br />

This data indicates, for the first time, an association between GAA<br />

non-coding repeats and aberrant pre-mRNA processing and suggests<br />

an alteration <strong>of</strong> the coordination between transcription and pre-mRNA<br />

processing in this disease . Transcribed GAA repeats might create a<br />

“decoy” exon that binding to trans acting splicing factors may interfere<br />

with normal turnover <strong>of</strong> non-coding intronic RNA leading to degradation<br />

and lower transcript levels .<br />

c07.3<br />

mechanisms <strong>of</strong> mEcP2 function underlying Rett syndrome as<br />

revealed from overexpression and knock-down systems in vitro<br />

M. Vecsler 1,2 , A. J. Simon 1,3 , G. Rechavi 1,3 , N. Amariglio 1,3 , E. Gak 1,2 ;<br />

1 Sackler Faculty <strong>of</strong> Medicine, Tel Aviv University, Tel Aviv, Israel, 2 <strong>Genetics</strong> Institute,<br />

Sheba Medical Center, Tel Hashomer, Israel, 3 Cancer Research Center,<br />

Institute <strong>of</strong> Hematology, Sheba Medical Center, Tel Hashomer, Israel.<br />

Rett syndrome is a severe X-linked neurodevelopmental disorder<br />

mainly affecting girls and is the second common cause <strong>of</strong> mental retardation<br />

in girls after the Down syndrome . The methyl CpG-binding<br />

protein 2 (MeCP2), a ubiquitous transcriptional repressor interacting<br />

with the chromatin remodeling machinery, is considered a single<br />

causative factor <strong>of</strong> Rett syndrome and related phenotypes, and some<br />

autistic cases . Our present study is focusing on interaction between<br />

MeCP2 and chromatin proteins leading to changes in chromatin architecture<br />

and silencing <strong>of</strong> gene expression . Using confocal microscopy,<br />

we demonstrate that MeCP2 protein is localized at the nuclear heterochromatin<br />

compartment together with the heterochromatin protein 1<br />

alpha (HP1α). In addition, we have developed in-vitro systems overexpressing<br />

the normal MeCP2 and MeCP2 containing Rett related mutations,<br />

as well as a knock-down system <strong>of</strong> the endogenous MECP2<br />

using specific siRNA. Studying these systems with a comprehensive<br />

gene regulation antibody array, we demonstrate that the expression <strong>of</strong><br />

a specific set <strong>of</strong> nuclear proteins, including hBRM/hSNF2a component<br />

<strong>of</strong> SWI/SNF, HMGB1 high mobility group protein, G9a histone methyltransferase,<br />

PRMT1 protein arginine methyltransferase and HDAC2<br />

histone deacetylase, is synchronized with MeCP2 overexpression and<br />

knock-down . Moreover using co-immunoprecipitation analyses, we<br />

demonstrate a direct interaction between MeCP2 and hBRM/hSNF2a<br />

component <strong>of</strong> ATPase-dependent SWI/SNF complex involved in global<br />

chromatin remodeling mechanism. Our findings suggest that MeCP2<br />

acts through parallel mechanism <strong>of</strong> chromatin remodeling involving<br />

HDACs and SWI/SNF complex, thereby inducing local as well as large<br />

scale changes in chromatin architecture and compaction .<br />

c07.4<br />

mutations in UBE are associated with X-linked infantile<br />

spinal muscular atrophy (XL-smA) and cause decreased gene<br />

expression in patients and carrier females<br />

A. Meindl1 , J. Ramser1 , C. Lenski1 , M. von Rhein2 , B. Wirth3 , K. O. Yariz4 , M. E.<br />

Ahearn4 , L. Baumbach-Reardon4 ;<br />

1Department <strong>of</strong> Obstetrics and Gynecology, Technical University Munich,<br />

Munich, Germany, 2University Children’s Hospital Mainz, Mainz, Germany,<br />

3 4 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, University <strong>of</strong> Cologne, Cologne, Germany, Miller<br />

School <strong>of</strong> Medicine, University <strong>of</strong> Miami, Miami, FL, United States.<br />

X-linked infantile spinal-muscular atrophy (XL-SMA; MIM301830) is a<br />

rare X-linked disorder that presents with the clinical features <strong>of</strong> hypotonia,<br />

areflexia and multiple congenital contractures (arthrogryposis)<br />

associated with anterior horn cell loss and infantile death . Large scale<br />

mutation analysis in the linkage interval (DXS8080-DXS7132) resulted<br />

in the detection <strong>of</strong> three rare novel variants in exon 15 <strong>of</strong> the gene<br />

coding for the Ubiquitin-Activating Enzyme E1 (UBE1): two missense<br />

mutations (c .1617 G>T, p .Met539Ile, c .1639 A>G, p .Ser547Gly) present<br />

each in one XL-SMA family and one synonymous C>T substitution<br />

(c.1731 C>T, p.Asn577Asn) identified in additional four unrelated<br />

families . Each <strong>of</strong> these variants was demonstrated to segregate with<br />

the disease . Absence <strong>of</strong> the missense mutations was demonstrated<br />

for 3550, absence <strong>of</strong> the silent mutation was shown in 7914 control<br />

X-chromosomes. These results yielded statistical significant evidence<br />

for the association <strong>of</strong> the silent substitution and the two missense mutations<br />

with XL-SMA (P = 2 .416x10-10 , P = 0 .001815) . We have also<br />

demonstrated that the silent C>T substitution leads to significant reduction<br />

<strong>of</strong> UBE1-expression in patients and interestingly to a lesser extent<br />

also in carrier females and alters the methylation pattern <strong>of</strong> exon<br />

15, implying a plausible role <strong>of</strong> this DNA element in developmental<br />

UBE1- expression in humans . UBE1 catalyzes in the ubiquitin-proteasome<br />

system (UPS) the first step in ubiquitin conjugation to mark cellular<br />

proteins for degradation . Our observations indicate that XL-SMA<br />

is part <strong>of</strong> a growing list <strong>of</strong> neurodegenerative disorders associated with<br />

defects in the ubiquitin-proteasome pathway .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!